Less data are available on economic burden of esophageal cancer in China over the past 20 years and the data's comparability are poor, especially in terms of population level or indirect burden. Direct medical expenditure is on the rise, and regional differences.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2017) studied this question.